Applied Therapeutics Inc (APLT)
9.625
+0.36
(+3.83%)
USD |
NASDAQ |
Nov 22, 16:00
9.39
-0.24
(-2.44%)
After-Hours: 20:00
Applied Therapeutics Free Cash Flow: -81.84M for Sept. 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
September 30, 2024 | -81.84M |
June 30, 2024 | -73.24M |
March 31, 2024 | -67.09M |
December 31, 2023 | -55.17M |
September 30, 2023 | -54.06M |
June 30, 2023 | -58.72M |
March 31, 2023 | -60.67M |
December 31, 2022 | -78.09M |
September 30, 2022 | -89.14M |
June 30, 2022 | -85.42M |
March 31, 2022 | -92.92M |
December 31, 2021 | -90.73M |
Date | Value |
---|---|
September 30, 2021 | -86.54M |
June 30, 2021 | -91.56M |
March 31, 2021 | -81.57M |
December 31, 2020 | -78.21M |
September 30, 2020 | -67.87M |
June 30, 2020 | -55.01M |
March 31, 2020 | -48.16M |
December 31, 2019 | -36.31M |
September 30, 2019 | -29.77M |
June 30, 2019 | -23.95M |
March 31, 2019 | -17.05M |
December 31, 2018 | -11.18M |
Free Cash Flow Range, Past 5 Years
-92.92M
Minimum
Mar 2022
-36.31M
Maximum
Dec 2019
-71.62M
Average
-75.66M
Median
Free Cash Flow Benchmarks
ResMed Inc | 1.347B |
Axonics Inc | 5.373M |
Organon & Co | 646.00M |
NovaBay Pharmaceuticals Inc | -4.812M |
Palatin Technologies Inc | -32.57M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -23.33M |
Free Cash Flow Per Share (Quarterly) | -0.1616 |
Free Cash Flow to Equity (Quarterly) | -23.33M |
Free Cash Flow Yield | -6.39% |